An interventional study of Doula Support Intervention in Pregnant HIV Positive Women, sponsored by University of Miami. Enrolling by invitation at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by University of Miami · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of BRIDGES (BReast and Infant feeding Doulas to address Gaps in Education and Support) is to develop, test and disseminate an HIV Doula education and support program to improve maternal/child health outcomes and reduce perinatal transmission.
University of Miami is the lead sponsor of 843 studies on the registry; 166 are open to participants now.
Of its 115 completed or terminated interventional studies of FDA-regulated products, 97 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Pregnant women with HIV will receive a structured doula support intervention in addition to routine clinical care. Participants will be paired with a trained study doula who provides prenatal and postnatal support from pregnancy through 12 weeks postpartum.
Behavioral: Doula Support Intervention
A trained study doula provides behavioral support, including prenatal education, adherence support, and lactation counseling, from pregnancy through 12 weeks postpartum.
Feasibility of Enrollment into the HIV Doula Program
Percentage of eligible participants approached for participation who enroll in the HIV Doula Program
Time frame: Baseline through 6 months
Acceptability of the HIV Doula Program (Participant Retention)
Percentage of enrolled participants who are retained at each protocol defined study visit during the 6-month follow-up period.
Time frame: Baseline through 6 months
Uptake of the HIV Doula Program by Preferred Language
Percentage of eligible individuals approached for participation who enroll in the HIV Doula Program, stratified by participant reported preferred language.
Time frame: Baseline through 6 months
Participants with Undetectable HIV Viral Load (<20 copies/mL)
Percentage of participants with undetectable HIV viral load, defined as \<20 copies/mL. Data is obtained from clinically collected tests as part of routine care and abstracted from participants' medical records.
Time frame: 9 months
Initiated Breastfeeding After Birth
Percentage of participants who initiated breastfeeding after babies' birth.
Time frame: 6 months
Plan to share: No — Due to confidentiality
Started Aug 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start Sep 2026 → Aug 2026, primary completion Sep 2027 → May 2027 and completion Sep 2027 → May 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.